Kiyonaga Glen K MD Seattle, WA - 98144

Kiyonaga Glen K MD is categorized under Operators of Nonresidential Buildings in Seattle, WA and active since 1987.

Kiyonaga Glen K MD was established in 1987, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Operators of Nonresidential Buildings business, which does work in the B2B market, and is classified as a Operators of Nonresidential Buildings, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Glen Kiyonaga at the company’s single location by writing to 2902 Beacon Avenue South, Seattle, Washington WA 98144 or by phoning (206) 322-1211. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Kiyonaga Glen K MD
Contact Person: Glen Kiyonaga
Address: 2902 Beacon Avenue South, Seattle, Washington 98144
Phone Number: (206) 322-1211
Website Address: polyclinic.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1987
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Operators of Nonresidential Buildings
SIC Code: 6512
NAICS Code: 6211110
Share This Business:

Kiyonaga Glen K MD was started in 1987 to provide professional Operators of Nonresidential Buildings under the SIC code 6512 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Glen Kiyonaga for inquiries that concern Kiyonaga Glen K MD by calling the company number (206) 322-1211, as your correspondence is most welcome. Additionally, the physical location of the single location of Kiyonaga Glen K MD can be found at the coordinates 47.5775,-122.31049 as well as the street address 2902 Beacon Avenue South in Seattle, Washington 98144.

For its online presence, you may visit Kiyonaga Glen K MD’s website at polyclinic.com and engage with its social media outlets through on Twitter and on Facebook.